Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1995 1
1997 1
1998 2
1999 3
2001 8
2002 5
2003 10
2004 7
2005 9
2006 10
2007 5
2008 18
2009 18
2010 24
2011 18
2012 22
2013 13
2014 12
2015 16
2016 10
2017 7
2018 7
2019 4
2020 5
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

214 results
Results by year
Filters applied: . Clear all
Page 1
Molecular tuning of farnesoid X receptor partial agonism.
Merk D, Sreeramulu S, Kudlinzki D, Saxena K, Linhard V, Gande SL, Hiller F, Lamers C, Nilsson E, Aagaard A, Wissler L, Dekker N, Bamberg K, Schubert-Zsilavecz M, Schwalbe H. Merk D, et al. Among authors: schubert zsilavecz m. Nat Commun. 2019 Jul 2;10(1):2915. doi: 10.1038/s41467-019-10853-2. Nat Commun. 2019. PMID: 31266946 Free PMC article.
Analysis of 4-fluoroamphetamine in cerumen after controlled oral application.
Meier SI, Petzel-Witt S, Schubert-Zsilavecz M, de Sousa Fernandes Perna EB, Theunissen EL, Ramaekers JG, Toennes SW. Meier SI, et al. Among authors: schubert zsilavecz m. Drug Test Anal. 2020 Jul;12(7):968-974. doi: 10.1002/dta.2796. Epub 2020 Apr 13. Drug Test Anal. 2020. PMID: 32246899
Structure optimization of a new class of PPARγ antagonists.
Hernandez-Olmos V, Knape T, Heering J, von Knethen A, Kilu W, Kaiser A, Wurglics M, Helmstädter M, Merk D, Schubert-Zsilavecz M, Parnham MJ, Steinhilber D, Proschak E. Hernandez-Olmos V, et al. Among authors: schubert zsilavecz m. Bioorg Med Chem. 2019 Nov 1;27(21):115082. doi: 10.1016/j.bmc.2019.115082. Epub 2019 Aug 27. Bioorg Med Chem. 2019. PMID: 31548084
[Antitussives and expectorants].
Sander K, Zettl H, Schubert-Zsilavecz M, Stark H. Sander K, et al. Among authors: schubert zsilavecz m. Pharm Unserer Zeit. 2008;37(6):462-71. doi: 10.1002/pauz.200800285. Pharm Unserer Zeit. 2008. PMID: 18956360 Review. German. No abstract available.
[Proton pump inhibitors].
Schubert-Zsilavecz M, Stark H. Schubert-Zsilavecz M, et al. Pharm Unserer Zeit. 2005;34(3):194-9. doi: 10.1002/pauz.200500118. Pharm Unserer Zeit. 2005. PMID: 15940951 Review. German. No abstract available.
First Structure-Activity Relationship Study of Potent BLT2 Agonists as Potential Wound-Healing Promoters.
Hernandez-Olmos V, Heering J, Planz V, Liu T, Kaps A, Rajkumar R, Gramzow M, Kaiser A, Schubert-Zsilavecz M, Parnham MJ, Windbergs M, Steinhilber D, Proschak E. Hernandez-Olmos V, et al. Among authors: schubert zsilavecz m. J Med Chem. 2020 Oct 22;63(20):11548-11572. doi: 10.1021/acs.jmedchem.0c00588. Epub 2020 Oct 6. J Med Chem. 2020. PMID: 32946232
l-Thyroxin and the Nonclassical Thyroid Hormone TETRAC Are Potent Activators of PPARγ.
Gellrich L, Heitel P, Heering J, Kilu W, Pollinger J, Goebel T, Kahnt A, Arifi S, Pogoda W, Paulke A, Steinhilber D, Proschak E, Wurglics M, Schubert-Zsilavecz M, Chaikuad A, Knapp S, Bischoff I, Fürst R, Merk D. Gellrich L, et al. Among authors: schubert zsilavecz m. J Med Chem. 2020 Jul 9;63(13):6727-6740. doi: 10.1021/acs.jmedchem.9b02150. Epub 2020 Jun 4. J Med Chem. 2020. PMID: 32356658
214 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page